BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34242824)

  • 1. [Epidemiologic and histopathologic characteristics of 1280 uterine cervical cancers in Kinshasa].
    Kajimina Katumbayi JC; Muyulu NP; Zakayi PK; Lebwaze Massamba B; Sitwaminya RK; Beya Kabongo F; Kisile Mikuwo O; Baleka AM; Kabongo Mpolesha JM; Nicaise M; Chirimwami RB
    Gynecol Obstet Fertil Senol; 2022 Jan; 50(1):53-61. PubMed ID: 34242824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
    Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
    Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric-type cervical adenocarcinoma with squamous differentiation: buried in adenosquamous carcinomas?
    Yoshida H; Naka T; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
    Virchows Arch; 2021 Aug; 479(2):407-412. PubMed ID: 33404855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological analysis of non-squamous cell malignancies of the uterine cervix in Maiduguri, Nigeria.
    Mayun AA; Nggada HA; Audu BM; Pindiga UH; Khalil MI; Musa AB
    Afr J Med Med Sci; 2008 Dec; 37(4):369-73. PubMed ID: 19301715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
    Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RETRACTED ARTICLE: Cervical adenosquamous carcinoma: detailed analysis of morphology, immunohistochemical profile, and clinical outcomes in 59 cases.
    Stolnicu S; Hoang L; Hanko-Bauer O; Barsan I; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Soslow RA
    Mod Pathol; 2019 Feb; 32(2):269-279. PubMed ID: 30258209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.
    Lei J; Andrae B; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Wang J; Fang F; Dillner J; Elfström KM; Sparén P
    BMJ; 2019 Apr; 365():l1207. PubMed ID: 30944091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival.
    Davy ML; Dodd TJ; Luke CG; Roder DM
    Obstet Gynecol; 2003 Jan; 101(1):38-45. PubMed ID: 12517643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic classification of cervical carcinomas and recognition of mucin-secreting squamous carcinomas.
    Colgan TJ; Auger M; McLaughlin JR
    Int J Gynecol Pathol; 1993 Jan; 12(1):64-9. PubMed ID: 8380284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
    Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
    BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis and treatment of primary adenocarcinoma and adenosquamous cell carcinoma of the uterine cervix.
    Pekin T; Kavak Z; Yildizhan B; Kaya H
    Eur J Gynaecol Oncol; 2001; 22(2):160-3. PubMed ID: 11446486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and pattern of HPV-16 immunostaining in uterine cervical carcinomas in Ethiopian women: a pilot study.
    Rashed MM; Bekele A
    Pan Afr Med J; 2011; 8():21. PubMed ID: 22121430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies.
    International Collaboration of Epidemiological Studies of Cervical Cancer
    Int J Cancer; 2007 Feb; 120(4):885-91. PubMed ID: 17131323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histopathology of squamous cell carcinoma and adenocarcinoma of the uterine cervix].
    Schmidt D; Horn LC; Kommoss F
    Pathologe; 2005 Jul; 26(4):255-61. PubMed ID: 15915328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.
    Pirog EC; Kleter B; Olgac S; Bobkiewicz P; Lindeman J; Quint WG; Richart RM; Isacson C
    Am J Pathol; 2000 Oct; 157(4):1055-62. PubMed ID: 11021808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytological history of 148 women presenting with invasive cervical cancer].
    Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
    Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for cervical cancer by histology.
    Brinton LA; Herrero R; Reeves WC; de Britton RC; Gaitan E; Tenorio F
    Gynecol Oncol; 1993 Dec; 51(3):301-6. PubMed ID: 8112636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models.
    Reimers LL; Anderson WF; Rosenberg PS; Henson DE; Castle PE
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):792-800. PubMed ID: 19258470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer.
    Cao L; Wen H; Feng Z; Han X; Wu X
    Int J Gynecol Cancer; 2019 Oct; 29(8):1244-1251. PubMed ID: 31422351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.